Cargando…
Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study
BACKGROUND: There is a well-documented empirical relationship between lipoprotein (a) [Lp(a)] and cardiovascular disease (CVD); however, causal evidence, especially from the Chinese population, is lacking. Therefore, this study aims to estimate the causal association between variants in genes affect...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170931/ https://www.ncbi.nlm.nih.gov/pubmed/34074296 http://dx.doi.org/10.1186/s12944-021-01482-0 |
_version_ | 1783702337439662080 |
---|---|
author | Xia, Juan Guo, Chunyue Liu, Kuo Xie, Yunyi Cao, Han Peng, Wenjuan Sun, Yanyan Liu, Xiaohui Li, Bingxiao Zhang, Ling |
author_facet | Xia, Juan Guo, Chunyue Liu, Kuo Xie, Yunyi Cao, Han Peng, Wenjuan Sun, Yanyan Liu, Xiaohui Li, Bingxiao Zhang, Ling |
author_sort | Xia, Juan |
collection | PubMed |
description | BACKGROUND: There is a well-documented empirical relationship between lipoprotein (a) [Lp(a)] and cardiovascular disease (CVD); however, causal evidence, especially from the Chinese population, is lacking. Therefore, this study aims to estimate the causal association between variants in genes affecting Lp(a) concentrations and CVD in people of Han Chinese ethnicity. METHODS: Two-sample Mendelian randomization analysis was used to assess the causal effect of Lp(a) concentrations on the risk of CVD. Summary statistics for Lp(a) variants were obtained from 1256 individuals in the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei. Data on associations between single-nucleotide polymorphisms (SNPs) and CVD were obtained from recently published genome-wide association studies. RESULTS: Thirteen SNPs associated with Lp(a) levels in the Han Chinese population were used as instrumental variables. Genetically elevated Lp(a) was inversely associated with the risk of atrial fibrillation [odds ratio (OR), 0.94; 95% confidence interval (95%CI), 0.901–0.987; P = 0.012)], the risk of arrhythmia (OR, 0.96; 95%CI, 0.941–0.990; P = 0.005), the left ventricular mass index (OR, 0.97; 95%CI, 0.949–1.000; P = 0.048), and the left ventricular internal dimension in diastole (OR, 0.97; 95%CI, 0.950–0.997; P = 0.028) according to the inverse-variance weighted method. No significant association was observed for congestive heart failure (OR, 0.99; 95% CI, 0.950–1.038; P = 0.766), ischemic stroke (OR, 1.01; 95%CI, 0.981–1.046; P = 0.422), and left ventricular internal dimension in systole (OR, 0.98; 95%CI, 0.960–1.009; P = 0.214). CONCLUSIONS: This study provided evidence that genetically elevated Lp(a) was inversely associated with atrial fibrillation, arrhythmia, the left ventricular mass index and the left ventricular internal dimension in diastole, but not with congestive heart failure, ischemic stroke, and the left ventricular internal dimension in systole in the Han Chinese population. Further research is needed to identify the mechanism underlying these results and determine whether genetically elevated Lp(a) increases the risk of coronary heart disease or other CVD subtypes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01482-0. |
format | Online Article Text |
id | pubmed-8170931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81709312021-06-03 Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study Xia, Juan Guo, Chunyue Liu, Kuo Xie, Yunyi Cao, Han Peng, Wenjuan Sun, Yanyan Liu, Xiaohui Li, Bingxiao Zhang, Ling Lipids Health Dis Research BACKGROUND: There is a well-documented empirical relationship between lipoprotein (a) [Lp(a)] and cardiovascular disease (CVD); however, causal evidence, especially from the Chinese population, is lacking. Therefore, this study aims to estimate the causal association between variants in genes affecting Lp(a) concentrations and CVD in people of Han Chinese ethnicity. METHODS: Two-sample Mendelian randomization analysis was used to assess the causal effect of Lp(a) concentrations on the risk of CVD. Summary statistics for Lp(a) variants were obtained from 1256 individuals in the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei. Data on associations between single-nucleotide polymorphisms (SNPs) and CVD were obtained from recently published genome-wide association studies. RESULTS: Thirteen SNPs associated with Lp(a) levels in the Han Chinese population were used as instrumental variables. Genetically elevated Lp(a) was inversely associated with the risk of atrial fibrillation [odds ratio (OR), 0.94; 95% confidence interval (95%CI), 0.901–0.987; P = 0.012)], the risk of arrhythmia (OR, 0.96; 95%CI, 0.941–0.990; P = 0.005), the left ventricular mass index (OR, 0.97; 95%CI, 0.949–1.000; P = 0.048), and the left ventricular internal dimension in diastole (OR, 0.97; 95%CI, 0.950–0.997; P = 0.028) according to the inverse-variance weighted method. No significant association was observed for congestive heart failure (OR, 0.99; 95% CI, 0.950–1.038; P = 0.766), ischemic stroke (OR, 1.01; 95%CI, 0.981–1.046; P = 0.422), and left ventricular internal dimension in systole (OR, 0.98; 95%CI, 0.960–1.009; P = 0.214). CONCLUSIONS: This study provided evidence that genetically elevated Lp(a) was inversely associated with atrial fibrillation, arrhythmia, the left ventricular mass index and the left ventricular internal dimension in diastole, but not with congestive heart failure, ischemic stroke, and the left ventricular internal dimension in systole in the Han Chinese population. Further research is needed to identify the mechanism underlying these results and determine whether genetically elevated Lp(a) increases the risk of coronary heart disease or other CVD subtypes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01482-0. BioMed Central 2021-06-01 /pmc/articles/PMC8170931/ /pubmed/34074296 http://dx.doi.org/10.1186/s12944-021-01482-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Xia, Juan Guo, Chunyue Liu, Kuo Xie, Yunyi Cao, Han Peng, Wenjuan Sun, Yanyan Liu, Xiaohui Li, Bingxiao Zhang, Ling Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study |
title | Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study |
title_full | Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study |
title_fullStr | Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study |
title_full_unstemmed | Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study |
title_short | Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study |
title_sort | association of lipoprotein (a) variants with risk of cardiovascular disease: a mendelian randomization study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170931/ https://www.ncbi.nlm.nih.gov/pubmed/34074296 http://dx.doi.org/10.1186/s12944-021-01482-0 |
work_keys_str_mv | AT xiajuan associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT guochunyue associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT liukuo associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT xieyunyi associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT caohan associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT pengwenjuan associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT sunyanyan associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT liuxiaohui associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT libingxiao associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy AT zhangling associationoflipoproteinavariantswithriskofcardiovasculardiseaseamendelianrandomizationstudy |